These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22751682)

  • 1. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
    Yamaguchi M; Weitzmann MN
    Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts.
    Yamaguchi M; Weitzmann MN
    Int J Mol Med; 2011 Oct; 28(4):521-5. PubMed ID: 21769418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.
    Yamaguchi M; Arbiser JL; Weitzmann MN
    Int J Mol Med; 2011 Dec; 28(6):1049-53. PubMed ID: 21887456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation.
    Yamaguchi M; Weitzmann MN
    Int J Mol Med; 2011 Jan; 27(1):3-14. PubMed ID: 21072493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
    Yamaguchi M; Weitzmann MN
    Mol Cell Biochem; 2011 Sep; 355(1-2):179-86. PubMed ID: 21533765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
    Yamaguchi M; Weitzmann MN
    Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition.
    Yamaguchi M; Moore TW; Sun A; Snyder JP; Shoji M
    Integr Biol (Camb); 2012 Aug; 4(8):905-13. PubMed ID: 22751853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.
    Yamaguchi M; Weitzmann MN; Murata T
    Mol Cell Biochem; 2012 Jan; 359(1-2):193-203. PubMed ID: 21842421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblasts.
    Yamaguchi M; Weitzmann MN
    Mol Med Rep; 2009; 2(4):641-4. PubMed ID: 21475879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis.
    Yamaguchi M; Vikulina T; Arbiser JL; Weitzmann MN
    Curr Mol Med; 2014; 14(6):783-92. PubMed ID: 25056540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.